Dolby Laboratories Misses on the Top and Bottom Lines
Dolby Laboratories (NYS: DLB) reported earnings on Aug. 2. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 29 (Q3), Dolby Laboratories missed estimates on revenue and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue shrank and GAAP earnings per share shrank.
Gross margins increased, operating margins contracted, and net margins shrank.
Dolby Laboratories chalked up revenue of $207.9 million. The nine analysts polled by S&P Capital IQ predicted revenue of $218.3 million on the same basis. GAAP reported sales were 5.1% lower than the prior-year quarter's $219.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.57. The six earnings estimates compiled by S&P Capital IQ averaged $0.58 per share. GAAP EPS of $0.48 for Q3 were 13% lower than the prior-year quarter's $0.55 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 89.9%, 270 basis points better than the prior-year quarter. Operating margin was 32.7%, 740 basis points worse than the prior-year quarter. Net margin was 24.8%, 340 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $231.3 million. On the bottom line, the average EPS estimate is $0.66.
Next year's average estimate for revenue is $941.3 million. The average EPS estimate is $2.83.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 3,962 members out of 4,057 rating the stock outperform, and 95 members rating it underperform. Among 998 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 980 give Dolby Laboratories a green thumbs-up, and 18 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Dolby Laboratories is hold, with an average price target of $48.14.
- Add Dolby Laboratories to My Watchlist.
The article Dolby Laboratories Misses on the Top and Bottom Lines originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Dolby Laboratories. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.